<\/p>\n
Medicana Sa\u011fl\u0131k Grubundan yap\u0131lan a\u00e7\u0131klamaya g\u00f6re, rahmin kas dokusundan kaynaklanan iyi huylu t\u00fcm\u00f6rler miyom olarak adland\u0131r\u0131l\u0131yor.<\/p>\n
Adet kanamas\u0131nda art\u0131\u015f, adet s\u00fcresinde uzama ve adet aras\u0131 kanama miyom belirtileri aras\u0131nda bulunuyor.<\/p>\n
Miyomlar her 3-4 kad\u0131ndan birinde g\u00f6r\u00fclebiliyor. Her miyom tedavi gerektirmezken bunlar\u0131n kanser \u00e7\u0131kma oran\u0131 y\u00fczde 1\u2019in alt\u0131nda bulunuyor. Rahim i\u00e7 duvar\u0131n\u0131n yap\u0131s\u0131n\u0131 etkileyen miyomlar ise k\u0131s\u0131rl\u0131\u011fa, gebelikte kanamaya ve hatta d\u00fc\u015f\u00fcklere neden olabiliyor.<\/p>\n
Medicana International Ankara Hastanesi Kad\u0131n Hastal\u0131klar\u0131 ve Do\u011fum Uzman\u0131 Do\u00e7. Dr. Emre G\u00fcnakan, miyomun \u0131rka g\u00f6re kad\u0131nlarda g\u00f6r\u00fclme oran\u0131n\u0131n y\u00fczde 50\u2019lere kadar ula\u015ft\u0131\u011f\u0131n\u0131 bildirdi.<\/p>\n
Hormon ba\u011f\u0131ml\u0131 bir t\u00fcm\u00f6r olan miyomlar\u0131n g\u00f6r\u00fclme s\u0131kl\u0131\u011f\u0131n\u0131n \u00fcreme \u00e7a\u011f\u0131ndaki kad\u0131nlarda artt\u0131\u011f\u0131na dikkati \u00e7eken G\u00fcnakan, \u00e7ocukluk ve ergenlik \u00e7a\u011f\u0131nda miyom g\u00f6r\u00fclmedi\u011fini ve mevcut olanlar\u0131n da menopozla birlikte k\u00fc\u00e7\u00fcld\u00fc\u011f\u00fcn\u00fc ifade etti.<\/p>\n
Bir\u00e7ok hastada belirti g\u00f6r\u00fclmedi\u011fine i\u015faret eden G\u00fcnakan, “Miyomda en s\u0131k hastaneye ba\u015fvuru sebebi kanamad\u0131r. Bu durum, adet kanamas\u0131ndaki art\u0131\u015f, s\u00fcrede uzama, adet aras\u0131 kanama \u015feklinde olabilir.” de\u011ferlendirmesinde bulundu.<\/p>\n
Miyom tan\u0131s\u0131nda en s\u0131k kullan\u0131lan y\u00f6ntemin ultrason oldu\u011fu bilgisini veren G\u00fcnakan, rahim i\u00e7 duvar\u0131nda yer alan miyomlar\u0131n tan\u0131s\u0131n\u0131n rahim a\u011fz\u0131ndan girilerek yap\u0131lan i\u015flemle konulabilece\u011fini hatta e\u015f zamanl\u0131 olarak miyomun \u00e7\u0131kar\u0131labilece\u011fini aktard\u0131.<\/p>\n
G\u00fcnakan, gebelikte miyom varl\u0131\u011f\u0131n\u0131n, yerine g\u00f6re d\u00fc\u015f\u00fck tehdidi, a\u011fr\u0131 ve kanama gibi risklerin art\u0131\u015f\u0131n\u0131 tetikleyebilece\u011fini kaydetti.<\/p>\n
Miyomlar\u0131n nadir de olsa k\u0131s\u0131rl\u0131\u011fa neden olabilece\u011fini belirten G\u00fcnakan, tedavi sonu\u00e7lar\u0131n\u0131n y\u00fcz g\u00fcld\u00fcr\u00fcc\u00fc oldu\u011funun alt\u0131n\u0131 \u00e7izdi.<\/p>\n
G\u00fcnakan miyomlar\u0131n takip veya tedavisinin yerine, b\u00fcy\u00fckl\u00fc\u011f\u00fcne, hastan\u0131n ya\u015f\u0131na, \u00fcreme \u00f6yk\u00fcs\u00fcne, klinik ve semptomlar\u0131n geneline bak\u0131larak planland\u0131\u011f\u0131n\u0131, her miyomun tedavi gerektirmedi\u011fini bildirdi.<\/p>\n